Palvella Therapeutics, Inc.
PVLA
$50.13
-$3.29-6.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 384.51% | 928.93% | 1,037.44% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 335.18% | -- | 1,059.60% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 380.62% | -- | 1,068.97% | -- | -- |
|
|
|||||
| Total Current Assets | 380.62% | -- | 1,068.97% | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 380.62% | -- | 1,068.97% | -- | -- |
|
|
|||||
| Total Accounts Payable | 215.15% | -- | 389.96% | -- | -- |
| Total Accrued Expenses | -20.68% | -- | 241.43% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1,156.71% | -- | 1,773.96% | -- | -- |
| Total Other Current Liabilities | 1,156.71% | -- | 1,773.96% | -- | -- |
| Total Current Liabilities | 118.79% | -- | 410.08% | -- | -- |
|
|
|||||
| Total Current Liabilities | 118.79% | -- | 410.08% | -- | -- |
| Long-Term Debt | -26.83% | -- | 48.27% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 37.01% | -- | 62.43% | -- | -- |
| Total Liabilities | 1.56% | -- | 124.25% | -- | -- |
|
|
|||||
| Common Stock & APIC | 7,203.16% | -- | 8,499.50% | -- | -- |
| Retained Earnings | -34.19% | -- | -22.85% | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 159.11% | 174.62% | 184.06% | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 159.11% | 174.62% | 184.06% | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 567.29% | 1,532.40% | 1,713.58% | -- | -- |
|
|
|||||